Australia
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1.19
|
June 30, 2024 | USD 1.81 | -0.10% |
|
Australia |
|
2 |
0.57
|
June 30, 2024 | USD 17.28 | 1.26% |
|
Australia |
|
3 |
0.21
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
4 |
0.13
|
June 30, 2024 | USD 185.40 | -0.68% |
|
Australia |
|
5 |
0.13
|
Dec. 31, 2023 | USD 1.27 | -1.68% |
|
Australia |
|
6 |
0.05
|
June 30, 2024 | USD 2.01 | -0.68% |
|
Australia |
|
7 |
0.01
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
The Medical Instruments company in Australia with the highest Debt to Equity Ratio is Integral Diagnostics Limited (ASX: IDX.AX) at 1.19.
The Medical Instruments company in Australia with the lowest Debt to Equity Ratio is Pro Medicus Limited (ASX: PME.AX) at 0.01.
The top 10 Medical Instruments companies in Australia by Debt to Equity Ratio are Integral Diagnostics Limited, Sonic Healthcare Limited, PolyNovo Limited, Cochlear Limited, Cyclopharm Limited, Nanosonics Limited and Pro Medicus Limited.
The bottom 10 Medical Instruments companies in Australia by Debt to Equity Ratio are Pro Medicus Limited, Nanosonics Limited, Cyclopharm Limited, Cochlear Limited, PolyNovo Limited, Sonic Healthcare Limited and Integral Diagnostics Limited.